These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15866473)

  • 1. Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis.
    Dutta A; Bandyopadhyay S; Mandal C; Chatterjee M
    Parasitol Int; 2005 Jun; 54(2):119-22. PubMed ID: 15866473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a semi-automated colorimetric assay for screening anti-leishmanial agents.
    Ganguly S; Bandyopadhyay S; Sarkar A; Chatterjee M
    J Microbiol Methods; 2006 Jul; 66(1):79-86. PubMed ID: 16316700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
    Pal S; Mandal A; Duttagupta S
    Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity.
    Kumar D; Kulshrestha A; Singh R; Salotra P
    Antimicrob Agents Chemother; 2009 Feb; 53(2):835-8. PubMed ID: 19015344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
    Sharief AH; Gasim Khalil EA; Theander TG; Kharazmi A; Omer SA; Ibrahim ME
    Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of antimony resistant kala-azar cured with amphotericin B].
    Chen SB; Yang CM; Zhang CJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
    Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
    J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models.
    Dube A; Singh N; Sundar S; Singh N
    Parasitol Res; 2005 Jun; 96(4):216-23. PubMed ID: 15868188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane sterol depletion impairs miltefosine action in wild-type and miltefosine-resistant Leishmania donovani promastigotes.
    Saint-Pierre-Chazalet M; Ben Brahim M; Le Moyec L; Bories C; Rakotomanga M; Loiseau PM
    J Antimicrob Chemother; 2009 Nov; 64(5):993-1001. PubMed ID: 19749205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
    Escobar P; Yardley V; Croft SL
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress.
    Deep DK; Singh R; Bhandari V; Verma A; Sharma V; Wajid S; Sundar S; Ramesh V; Dujardin JC; Salotra P
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005641. PubMed ID: 28575060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antileishmanial activity of drug infused mini-agar plates on Leishmania donovani promastigotes.
    Muniaraj M; Sinha PK; Das P
    Trop Biomed; 2010 Dec; 27(3):657-61. PubMed ID: 21399608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India.
    Singh N; Chatterjee M; Sundar S
    Parasit Vectors; 2014 Dec; 7():596. PubMed ID: 25515494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
    J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs.
    Hadighi R; Boucher P; Khamesipour A; Meamar AR; Roy G; Ouellette M; Mohebali M
    Parasitol Res; 2007 Oct; 101(5):1319-22. PubMed ID: 17610079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK
    Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance.
    Bhandari V; Kumar D; Verma S; Srividya G; Negi NS; Singh R; Salotra P
    Biochem Biophys Res Commun; 2013 Nov; 440(4):646-51. PubMed ID: 24103752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of correlation between the promastigote back-transformation assay and miltefosine treatment outcome.
    Hendrickx S; Eberhardt E; Mondelaers A; Rijal S; Bhattarai NR; Dujardin JC; Delputte P; Cos P; Maes L
    J Antimicrob Chemother; 2015 Nov; 70(11):3023-6. PubMed ID: 26253089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short report: fluorescent Leishmania: application to anti-leishmanial drug testing.
    Singh N; Dube A
    Am J Trop Med Hyg; 2004 Oct; 71(4):400-2. PubMed ID: 15516633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania resistance to miltefosine associated with genetic marker.
    Cojean S; Houzé S; Haouchine D; Huteau F; Lariven S; Hubert V; Michard F; Bories C; Pratlong F; Le Bras J; Loiseau PM; Matheron S
    Emerg Infect Dis; 2012 Apr; 18(4):704-6. PubMed ID: 22469394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.